首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Entinostat/pembrolizumabLack of efficacy: case report
被引:0
作者
:
机构
:
来源
:
Reactions Weekly
|
2023年
/ 1938卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-023-30736-9
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:595 / 595
相关论文
共 50 条
[21]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2022,
1910
(1)
:393
-393
[22]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2021,
1844
(1)
:367
-367
[23]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1978
(1)
:314
-314
[24]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2024,
2030
(1)
:420
-420
[25]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2022,
1909
(1)
:456
-456
[26]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2022,
1924
(1)
:365
-365
[27]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1939
(1)
:378
-378
[28]
PembrolizumabLack of efficacy : case report
[J].
Reactions Weekly,
2023,
1951
(1)
:276
-276
[29]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2025,
2057
(1)
:305
-305
[30]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2024,
2034
(1)
:319
-319
←
1
2
3
4
5
→
共 50 条
[21]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2022,
1910
(1)
:393
-393
[22]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2021,
1844
(1)
:367
-367
[23]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1978
(1)
:314
-314
[24]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2024,
2030
(1)
:420
-420
[25]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2022,
1909
(1)
:456
-456
[26]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2022,
1924
(1)
:365
-365
[27]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1939
(1)
:378
-378
[28]
PembrolizumabLack of efficacy : case report
[J].
Reactions Weekly,
2023,
1951
(1)
:276
-276
[29]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2025,
2057
(1)
:305
-305
[30]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2024,
2034
(1)
:319
-319
←
1
2
3
4
5
→